| Schedule of Breakdown of Significant Operating Expenses |
Schedule
of Breakdown of Significant Operating Expenses
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three months ended June 30, | | |
Six months ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Operating expenses: | |
| | | |
| | | |
| | | |
| | |
| Research and development by significant expense: | |
| | | |
| | | |
| | | |
| | |
| Study fees | |
$ | 2,008 | | |
$ | 60 | | |
$ | 3,275 | | |
$ | 412 | |
| Payroll and related | |
| 359 | | |
| 114 | | |
| 595 | | |
| 211 | |
| Professional fees | |
| 173 | | |
| 202 | | |
| 337 | | |
| 358 | |
| MSA/license fees | |
| 131 | | |
| 663 | | |
| 200 | | |
| 1,300 | |
| Other1 | |
| 121 | | |
| 97 | | |
| 300 | | |
| 164 | |
| | |
| | | |
| | | |
| | | |
| | |
| Research and development | |
| 2,792 | | |
| 1,136 | | |
| 4,707 | | |
| 2,445 | |
| | |
| | | |
| | | |
| | | |
| | |
| General and administrative by significant expense: | |
| | | |
| | | |
| | | |
| | |
| Payroll and related2 | |
| 421 | | |
| 428 | | |
| 1,223 | | |
| 821 | |
| Professional fees2 | |
| 391 | | |
| 440 | | |
| 838 | | |
| 826 | |
| Stock-based compensation | |
| 300 | | |
| 353 | | |
| 596 | | |
| 839 | |
| Other2 | |
| 200 | | |
| 144 | | |
| 286 | | |
| 300 | |
| General and administrative | |
| 1,312 | | |
| 1,365 | | |
| 2,943 | | |
| 2,786 | |
| | |
| | | |
| | | |
| | | |
| | |
| Impairment of goodwill | |
| - | | |
| - | | |
| 2,044 | | |
| - | |
| | |
| | | |
| | | |
| | | |
| | |
| Total operating expenses | |
| 4,104 | | |
| 2,501 | | |
| 9,694 | | |
| 5,231 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss from operations | |
| (4,104 | ) | |
| (2,501 | ) | |
| (9,694 | ) | |
| (5,231 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Forward sales contract expense | |
| - | | |
| (512 | ) | |
| - | | |
| (5,847 | ) |
| Change in fair value of warrant liabilities | |
| - | | |
| - | | |
| - | | |
| 1 | |
| Interest income (expense), net | |
| 55 | | |
| - | | |
| 99 | | |
| 5 | |
| Gain on extinguishment of contingent liability | |
| 41 | | |
| - | | |
| 41 | | |
| - | |
| Other expense, net | |
| (1 | ) | |
| (123 | ) | |
| (1 | ) | |
| (258 | ) |
| Total other income (expense), net | |
| 95 | | |
| (635 | ) | |
| 139 | | |
| (6,099 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Benefit (provision) for income taxes | |
| - | | |
| (3 | ) | |
| 40 | | |
| (11 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
$ | (4,009 | ) | |
$ | (3,139 | ) | |
$ | (9,515 | ) | |
$ | (11,341 | ) |
| | |
June 30, 2026 | | |
December 31, 2025 | |
| | |
| | | |
| | |
| Cash | |
$ | 5,028 | | |
$ | 1,884 | |
| 1 | | Other includes certain lab
supply expenses, travel expenses, stock-based compensation, allocated occupancy costs, and depreciation. |
| 2 | | Other includes expenses
related to insurance, occupancy expense, information technology, travel, depreciation and other miscellaneous expenses. |
|